BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 33496334)

  • 1. Syndemics & syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era.
    Nikiphorou E; Alpizar-Rodriguez D; Gastelum-Strozzi A; Buch M; Peláez-Ballestas I
    Rheumatology (Oxford); 2021 May; 60(5):2040-2045. PubMed ID: 33496334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the COVID-19 pandemic on people with rheumatic and musculoskeletal diseases: insights from patient-generated data on social media.
    Reuter K; Deodhar A; Makri S; Zimmer M; Berenbaum F; Nikiphorou E
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI77-SI84. PubMed ID: 33629107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1).
    Garrido-Cumbrera M; Marzo-Ortega H; Christen L; Plazuelo-Ramos P; Webb D; Jacklin C; Irwin S; Grange L; Makri S; Frazão Mateus E; Mingolla S; Antonopoulou K; Sanz-Gómez S; Correa-Fernández J; Carmona L; Navarro-Compán V
    RMD Open; 2021 Apr; 7(1):. PubMed ID: 33827969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic.
    Ahmed S; Gasparyan AY; Zimba O
    Rheumatol Int; 2021 Feb; 41(2):243-256. PubMed ID: 33388969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations.
    Kroon FPB; Najm A; Alunno A; Schoones JW; Landewé RBM; Machado PM; Navarro-Compán V
    Ann Rheum Dis; 2022 Mar; 81(3):422-432. PubMed ID: 34876462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health inequalities and social determinants of health: The role of syndemics in rheumatic diseases.
    Gilcrease GW; Sciascia S; Padovan D; Sciullo A; Cioffi M; Ricceri F; Radin M; Schreiber K; Husum D; Roccatello D; Nikiphorou E
    Autoimmun Rev; 2023 Jul; 22(7):103351. PubMed ID: 37121530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases.
    Kearsley-Fleet L; Chang ML; Lawson-Tovey S; Costello R; Fingerhutová Š; Švestková N; Belot A; Aeschlimann FA; Melki I; Koné-Paut I; Eulert S; Kallinich T; Berkun Y; Uziel Y; Raffeiner B; Oliveira Ramos F; Clemente D; Dackhammar C; Wulffraat NM; Waite H; Strangfeld A; Mateus EF; Machado PM; ; ; Natter M; Hyrich KL
    Ann Rheum Dis; 2022 Jul; 81(7):998-1005. PubMed ID: 35338032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Syndemic Perspective on the Management of Non-communicable Diseases Amid the COVID-19 Pandemic in Low- and Middle-Income Countries.
    Yadav UN; Rayamajhee B; Mistry SK; Parsekar SS; Mishra SK
    Front Public Health; 2020; 8():508. PubMed ID: 33102414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of podiatry telephone appointments for people with rheumatic and musculoskeletal diseases.
    Palmer JL; Siddle HJ; Redmond AC; Alcacer-Pitarch B
    J Foot Ankle Res; 2021 Jan; 14(1):4. PubMed ID: 33413562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha
    Dejaco C; Bijlsma JW; Buttgereit F
    Ann Rheum Dis; 2021 Oct; 80(10):e171. PubMed ID: 33509796
    [No Abstract]   [Full Text] [Related]  

  • 11. Inequity and vulnerability in Latin American Indigenous and non-Indigenous populations with rheumatic diseases: a syndemic approach.
    Granados Y; Gastelum Strozzi A; Alvarez-Nemegyei J; Quintana R; Julian-Santiago F; Santos AM; Guevara-Pacheco S; Loyola-Sanchez A; Goycochea-Robles MV; Juarez V; Garza-Elizondo MA; Rueda JC; Burgos-Vargas R; Londoño J; Pons-Estel BA; Pelaez-Ballestas I; ;
    BMJ Open; 2023 Mar; 13(3):e069246. PubMed ID: 36958782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndemic contexts: findings from a review of research on non-communicable diseases and interviews with experts.
    Pirrone I; Dieleman M; Reis R; Pell C
    Glob Health Action; 2021 Jan; 14(1):1927332. PubMed ID: 34308786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'.
    Al Nokhatha S; MacEoin N; Conway R
    Ann Rheum Dis; 2021 Oct; 80(10):e170. PubMed ID: 33509797
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19: A Syndemic Requiring an Integrated Approach for Marginalized Populations.
    Caron RM; Adegboye ARA
    Front Public Health; 2021; 9():675280. PubMed ID: 34046392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidities and Syndemics in the COVID-19 Age: Challenges and Opportunities for Bringing Separated Branches of Medicine Closer to Each Other.
    Jakovljevic M; Samarzija M; Milicic D; Reiner Z; Sartorius N
    Psychiatr Danub; 2021; 33(Suppl 4):402-413. PubMed ID: 34718258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches.
    Simões D; Araújo FA; Monjardino T; Severo M; Cruz I; Carmona L; Lucas R
    Rheumatol Int; 2018 May; 38(5):905-915. PubMed ID: 29423535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COVID-19 pandemic social restriction measures on people with rheumatic and musculoskeletal diseases in the UK: a mixed-methods study.
    Smith TO; Belderson P; Dainty JR; Birt L; Durrant K; Chipping JR; Tsigarides J; Yates M; Naughton F; Werry S; Notley C; Shepstone L; MacGregor AJ
    BMJ Open; 2021 Jun; 11(6):e048772. PubMed ID: 34083347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Syndemic, infodemic, pandemic of COVID-19: Towards a pandemiology of emerging diseases].
    Almeida-Filho N
    Salud Colect; 2021 Nov; 17():e3748. PubMed ID: 34752025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remotely delivered physiotherapy: can we capture the benefits beyond COVID-19?
    Bearne LM; Gregory WJ; Hurley MV
    Rheumatology (Oxford); 2021 Apr; 60(4):1582-1584. PubMed ID: 33547773
    [No Abstract]   [Full Text] [Related]  

  • 20. The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases.
    Al Maini M; Adelowo F; Al Saleh J; Al Weshahi Y; Burmester GR; Cutolo M; Flood J; March L; McDonald-Blumer H; Pile K; Pineda C; Thorne C; Kvien TK
    Clin Rheumatol; 2015 May; 34(5):819-29. PubMed ID: 25501633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.